These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38104929)

  • 1. Treated Cases of Retinopathy of Prematurity in Germany: 10-Year Data from the Retina.net Retinopathy of Prematurity Registry.
    Pfeil JM; Barth T; Lagrèze WA; Lorenz B; Hufendiek K; Liegl R; Breuss H; Bemme S; Aisenbrey S; Glitz B; Süsskind D; Gabel-Pfisterer A; Skevas C; Krohne TU; Kakkassery V; Bründer MC; Engelmann K; Guthoff R; Walter P; Choritz L; Stahl A;
    Ophthalmol Retina; 2024 Jun; 8(6):579-589. PubMed ID: 38104929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidemiology and treatment of retinopathy of prematurity. The Hannover data in the Retina.net ROP registry from 2001-2017].
    Akman SH; Pfeil JM; Stahl A; Ehlers S; Böhne C; Bohnhorst B; Framme C; Brockmann D; Bajor A; Jacobsen C; Hufendiek K; Pielen A;
    Ophthalmologe; 2022 May; 119(5):497-505. PubMed ID: 34811591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparability of input parameters in the German Retina.net ROP registry and the EU-ROP registry - An exemplary comparison between 2011 and 2021.
    Winter K; Pfeil JM; Engmann H; Aisenbrey S; Lorenz B; Hufendiek K; Breuss H; Khattab M; Süsskind D; Kakkassery V; Lagrèze WA; Barth T; Liegl R; Bründer MC; Skevas C; Goldammer I; Glitz B; Michalewicz E; Krohne TU; Bartmann IR; Stahl A;
    Acta Ophthalmol; 2024 May; 102(3):e314-e321. PubMed ID: 37725047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The German ROP Registry: data from 90 infants treated for retinopathy of prematurity.
    Walz JM; Bemme S; Pielen A; Aisenbrey S; Breuß H; Alex AF; Wagenfeld L; Schiedel S; Krohne TU; Stahl A;
    Acta Ophthalmol; 2016 Dec; 94(8):e744-e752. PubMed ID: 27197876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treated cases of retinopathy of prematurity in Germany : 5-year data from the Retina.net ROP registry].
    Walz JM; Bemme S; Reichl S; Akman S; Breuß H; Süsskind D; Glitz B; Müller VC; Wagenfeld L; Gabel-Pfisterer A; Aisenbrey S; Engelmann K; Koutsonas A; Krohne TU; Stahl A;
    Ophthalmologe; 2018 Jun; 115(6):476-488. PubMed ID: 29637302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Bevacizumab, Ranibizumab, and Laser Photocoagulation in the Treatment of Retinopathy of Prematurity in Turkey.
    Gunay M; Sukgen EA; Celik G; Kocluk Y
    Curr Eye Res; 2017 Mar; 42(3):462-469. PubMed ID: 27420302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment for retinopathy of prematurity in Sweden 2008-2021: Reduced gestational age of treated infants and remaining differences in treatment type and recurrence rates between hospitals.
    Holmström G; Hellström A; Teär Fahnehjelm K; Gränse L; Sandgren Hochhard K; Sunnqvist B; Tornqvist K; Tsamadou D; Wallin A; Larsson E
    Acta Ophthalmol; 2024 Jun; 102(4):401-408. PubMed ID: 37698061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison in Retreatments between Bevacizumab and Ranibizumab Intravitreal Injections for Retinopathy of Prematurity: A Multicenter Study.
    Patel NA; Acaba-Berrocal LA; Hoyek S; Fan KC; Martinez-Castellanos MA; Baumal CR; Harper CA; Berrocal AM;
    Ophthalmology; 2023 Apr; 130(4):373-378. PubMed ID: 36396121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal Detachment after Treatment of Retinopathy of Prematurity with Laser versus Intravitreal Anti-Vascular Endothelial Growth Factor.
    Barry GP; Yu Y; Ying GS; Tomlinson LA; Lajoie J; Fisher M; Binenbaum G;
    Ophthalmology; 2021 Aug; 128(8):1188-1196. PubMed ID: 33387554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivation of retinopathy of prematurity after ranibizumab treatment.
    Wong RK; Hubschman S; Tsui I
    Retina; 2015 Apr; 35(4):675-80. PubMed ID: 25768252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RATES AND RISK FACTORS FOR RECURRENCE OF RETINOPATHY OF PREMATURITY AFTER LASER OR INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR MONOTHERAPY.
    Ling KP; Liao PJ; Wang NK; Chao AN; Chen KJ; Chen TL; Hwang YS; Lai CC; Wu WC
    Retina; 2020 Sep; 40(9):1793-1803. PubMed ID: 31800460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.
    Sankar MJ; Sankar J; Chandra P
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD009734. PubMed ID: 29308602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity: A 5-Year Retrospective Analysis.
    Hwang CK; Hubbard GB; Hutchinson AK; Lambert SR
    Ophthalmology; 2015 May; 122(5):1008-15. PubMed ID: 25687024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five years of treatment for retinopathy of prematurity in Sweden: results from SWEDROP, a national quality register.
    Holmström G; Hellström A; Jakobsson P; Lundgren P; Tornqvist K; Wallin A
    Br J Ophthalmol; 2016 Dec; 100(12):1656-1661. PubMed ID: 26969711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in treatment of retinopathy of prematurity in the Netherlands from 2010 to 2017.
    Trzcionkowska K; Vehmeijer WBHJ; Kerkhoff FT; Bauer NJC; Bennebroek CAM; Dijk PH; Dijkman KP; van den Dungen FAM; Eggink CA; Feenstra RPG; Groenendaal F; van Heijst AF; van der Hoeven MAHBM; Kornelisse RF; Kraal-Biezen E; Lopriore E; Onland W; Renardel de Lavalette VW; van Rijn LJ; Schuerman FABA; Simonsz HJ; Voskuil-Kerkhof ESM; Witlox RSGM; Termote JUM; Schalij-Delfos NE
    Acta Ophthalmol; 2021 Feb; 99(1):97-103. PubMed ID: 32701185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Intravitreal Bevacizumab, Intravitreal Ranibizumab and Laser Photocoagulation for Treatment of Type 1 Retinopathy of Prematurity in Turkish Preterm Children.
    Kabataş EU; Kurtul BE; Altıaylık Özer P; Kabataş N
    Curr Eye Res; 2017 Jul; 42(7):1054-1058. PubMed ID: 28128986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity: The FIREFLEYE Randomized Clinical Trial.
    Stahl A; Sukgen EA; Wu WC; Lepore D; Nakanishi H; Mazela J; Moshfeghi DM; Vitti R; Athanikar A; Chu K; Iveli P; Zhao F; Schmelter T; Leal S; Köfüncü E; Azuma N;
    JAMA; 2022 Jul; 328(4):348-359. PubMed ID: 35881122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New modifications of Swedish ROP guidelines based on 10-year data from the SWEDROP register.
    Holmström G; Hellström A; Gränse L; Saric M; Sunnqvist B; Wallin A; Tornqvist K; Larsson E
    Br J Ophthalmol; 2020 Jul; 104(7):943-949. PubMed ID: 31676594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of intravitreal bevacizumab for zone-II retinopathy of prematurity.
    Karkhaneh R; Khodabande A; Riazi-Eafahani M; Roohipoor R; Ghassemi F; Imani M; Dastjani Farahani A; Ebrahimi Adib N; Torabi H
    Acta Ophthalmol; 2016 Sep; 94(6):e417-20. PubMed ID: 27009449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Incidence and Timing of Treatment-Requiring Retinopathy of Prematurity in Nanopremature and Micropremature Infants in the United States: A National Multicenter Retrospective Cohort Study.
    Scarboro SD; Harper CA; Karsaliya G; Ghoraba H; Moshfeghi DM; Al-Khersan H; Robles-Holmes HK; Fan KC; Berrocal AM; Hoyek S; Patel NA; Sbrocca R; Capone A; Drenser KA; Wood EH
    Ophthalmol Retina; 2024 Mar; 8(3):279-287. PubMed ID: 37838276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.